|
Status |
Public on Feb 13, 2015 |
Title |
A Methylation-Based Signature Predicts Survival In Hepatocellular Carcinoma Patient |
Organism |
Homo sapiens |
Experiment type |
Methylation profiling by genome tiling array
|
Summary |
Epigenetic deregulation is a critical event in human malignancies. A number of DNA methylation markers are currently under evaluation as diagnostic and prognostic biomarkers for many cancers. However, its potential role in hepatocellular carcinoma (HCC) is under-explored. Aims: To develop a DNA methylation-based prognostic signature in surgically resected HCC
|
|
|
Overall design |
Tumors from 224 HCC resected patients, 10 normal Liver individuals and 9 Cirrhotic patients were analyzed. Methylome profiling was done with Illumina HumanMethylation450 (485,000 CpG, 96% of known CpG islands). We selected probes in CpG islands located in promoters, hypermethylated (B value higher than 50%) in at least 5% of the tumors and hypomethylated (B value lower than 33%) in more than 90% of normal liver.
|
|
|
Contributor(s) |
Portela A, Esteller M, Villanueva A, Llovet J |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
Submission date |
Apr 08, 2014 |
Last update date |
Mar 22, 2019 |
Contact name |
Manel Esteller |
Organization name |
IDIBELL
|
Department |
PEBC
|
Lab |
Cancer Epigenetics
|
Street address |
Hospital Duran i Reynals Av. Gran Via s/n km, 2.7
|
City |
L'Hospitalet de Llobregat |
State/province |
Barcelona |
ZIP/Postal code |
08908 |
Country |
Spain |
|
|
Platforms (1) |
GPL13534 |
Illumina HumanMethylation450 BeadChip (HumanMethylation450_15017482) |
|
Samples (243)
|
|
Relations |
BioProject |
PRJNA244008 |